The Michael G. DeGroote Institute for Infectious Disease Research (IIDR) at McMaster University is a world-leading centre of transdisciplinary infectious disease research.
Since its inception in 2007, through an unprecedented gift from Hamilton businessman Michael G. DeGroote, the IIDR has attracted a unique group of experienced principal investigators who are engaged in life-altering work in the fields of virology, immunology, bacterial pathogenesis and population biology and epidemiology.
With distinctive strengths in basic and clinical antimicrobial and infectious disease research, the IIDR has become synonymous with innovation in the area of antimicrobial resistance. Using state-of-the-art infrastructure in drug discovery, genomics and bioinformatics, our investigators collaborate to develop novel approaches to speed the discovery of new antibiotics, and track and characterize resistance before it emerges in the clinic.
The IIDR is also home to over 300 graduate students, post-doctoral and clinical fellows, all of whom are involved in cutting-edge research in our advanced facilities, including the Centre for Microbial Chemical Biology (CMCB) – a 12,000-square-foot space that features six integrated labs, enabling chemical biology research to be conducted in one central location.
Committed to advancing the next generation of antimicrobial strategies for the diagnosis, treatment and prevention of infectious diseases, the IIDR is bridging the laboratory and the marketplace, positioning McMaster University at the forefront of infectious disease research.